Genetic variation and cognitive dysfunction one year after cardiac surgery

Anaesthesia

Volumn 68, Issue 6, 2013, Pages 571-575

  Stewart, A ^a   Katznelson, R ^a   Kraeva, N ^a   Carroll, J ^a   Pickworth, T ^a   Rao, V ^a   Djaiani, G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GLYCOPROTEIN IIIA;

AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART SURGERY; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COGNITIVE DYSFUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURGICAL TECHNIQUE;

AGED; APOLIPOPROTEINS E; CARDIAC SURGICAL PROCEDURES; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; HUMANS; INTEGRIN BETA3; MALE; NEUROPSYCHOLOGICAL TESTS; POSTOPERATIVE COMPLICATIONS;

EID: 84877767277     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12170     Document Type: Article

References (35)

1. Djaiani G, Katznelson R, Fedorko L, et al. Early benefit of preserved cognitive function is not sustained at one-year after cardiac surgery: a longitudinal follow-up of the randomized controlled trial. Canadian Journal of Anesthesia 2012; 59: 449-55.
2. Abildstrom H, Rasmussen LS, Rentowl P, et al. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. International study of post-operative cognitive dysfunction. Acta Anaesthesiologica Scandinavica 2000; 44: 1246-51.
3. Selnes OA, Grega MA, Bailey MM, et al. Cognition 6 years after surgical or medical therapy for coronary artery disease. Annals of Neurology 2008; 63: 581-90.
4. Sweet JJ, Finnin E, Wolfe PL, et al. Absence of cognitive decline one year after coronary bypass surgery: comparison to nonsurgical and healthy controls. Annals of Thoracic Surgery 2008; 85: 1571-8.
5. Selnes OA, Grega MA, Borowicz LM Jr, et al. Cognitive outcomes three years after coronary artery bypass surgery: a comparison of on-pump coronary artery bypass graft surgery and nonsurgical controls. Annals of Thoracic Surgery 2005; 79: 1201-9.
6. van Djik D, Moons KG, Nathoe HM, et al. Cognitive outcomes five years after not undergoing coronary artery bypass graft surgery. Annals of Thoracic Surgery 2008; 85: 60-4.
7. Djaiani G, Fedorko L, Borger MA, et al. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary artery bypass surgery. Circulation 2007; 116: 1888-95.
8. Mathew JP, Rinder CS, Howe JG, et al. Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Annals of Thoracic Surgery 2001; 71: 663-6.
9. Grocott HP, White WD, Morris RW, et al. Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke 2005; 36: 1854-8.
10. Mathew JP, Podgoreanu MV, Grocott HP, et al. Genetic variants in p-selectin and c-reactive protein influence susceptibility to cognitive decline after cardiac surgery. Journal of the American College of Cardiology 2007; 49: 1934-42.
11. Gunstad J, Benitez A, Hoth KF, et al. P-selectin 1087G/A polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease. Stroke 2009; 40: 2969-72.
12. Szolnoki Z, Somogyvári F, Kondacs A, et al. Increased prevalence of platelet glycoprotein IIb/IIIa PLA2 allele in ischaemic stroke associated with large vessel pathology. Thrombosis Research 2003; 109: 265-9.
13. Tardiff BE, Newman MF, Sounders AM, et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Annals of Thoracic Surgery 1997; 64: 715-20.
14. McDonagh DL, Mathew JP, White WD, et al. Cognitive function after major noncardiac surgery, apolipoprotein E4 genotype, and biomarkers of brain injury. Anesthesiology 2010; 112: 852-9.
15. Steed L, Kong R, Stygall J, et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Annals of Thoracic Surgery 2001; 71: 823-6.
16. Silbert BS, Evered LA, Scott DA, Cowie TF,. The apolipoprotein E Cyrillic small letter Ukrainian ie4 is not associated with cognitive dysfunction in cardiac surgery. Annals of Thoracic Surgery 2008; 86: 841-7.
17. Kim HO, Jin Y, Kickler TS, et al. Gene frequencies of the five major human platelet antigens in Afro Carribean, white, and Korean populations. Transfusion 1995; 35: 863-7.
18. Nurden AT,. Polymorphisms of human platelet membrane glycoproteins. Journal of Thrombosis and Haemostasis 1995; 74: 345-51.
19. Ridker PM, Hennekens CH, Schmitz C, et al. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385-8.
20. Feng D, Lindpaintner K, Larson MG, et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study. Arteriosclerosis, Thrombosis, and Vascular Biology 1999; 19: 961-7.
21. Michelson AD, Furman MI, Goldschmidt-Clermont P, et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000; 101: 1013-8.
22. Zotz RB, Klein M, Dauben HP, et al. Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PlA2) is a risk factor for bypass occlusion, myocardial infarction, and death. Journal of Thrombosis and Haemostasis 2000; 83: 404-7.
23. Potapov EV, Ignatenko S, Nasseri BA, et al. Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during long-term VAD support. Annals of Thoracic Surgery 2004; 77: 869-74.
24. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New England Journal of Medicine 1996; 334: 1090-4.
25. A and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arteriosclerosis, Thrombosis, and Vascular Biology 1998; 18: 1124-31.
26. Engelborghs S, Dermaut B, Goeman J, et al. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74: 1148-51.
27. Lahoz C, Schaefer EJ, Cupples LA, et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001; 154: 529-37.
28. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
29. Ti LK, Mackensen GB, Grocott HP, et al. Neurologic Outcome Research Group: Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients. Journal of Thoracic and Cardiovascular Surgery 2003; 125: 211-3.
30. Bryson GL, Wyand A, Wozny D, Rees L, Taljaard M, Nathan H,. A prospective cohort study evaluating associations among delirium, postoperative cognitive dysfunction, and apolipoprotein E genotype following open aortic repair. Canadian Journal of Anesthesia 2011; 58: 246-55.
31. Wijeysundera D, Katznelson R,. The how and why of "negative" research studies. Canadian Journal of Anesthesia 2011; 58: 233-9.
32. Monk TG, Weldon BC, Garvan CW, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008; 108: 18-30.
33. Steinmetz J, Christensen KB, Lund T, Lohse N, Rasmussen LS,. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology 2009; 110: 548-55.
34. Phillips-Bute B, Mathew JP, Blumenthal JA, et al. Association of neurocognitive function and quality of life 1 year after coronary artery graft (CABG) surgery. Psychosomatic Medicine 2006; 68: 369-75.
35. Newman MF, Grocott HP, Mathew JP, et al. Report of the sub-study assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke 2001; 32: 2874-81.